CBD Disrupts the Metabolic Fuel Supply of Colorectal Cancer Cells
CBD inhibited colorectal cancer cell proliferation by targeting the HIF-1alpha/LDHA glycolysis pathway, cutting off the abnormal glucose metabolism that fuels tumor growth.
Quick Facts
What This Study Found
CBD downregulated HIF-1alpha, LDHA, and GLUT1, reducing ATP production, glucose uptake, and lactate levels in colon cancer cells. When combined with glycolysis inhibitor 2-DG, the anti-tumor effects were enhanced, confirming pathway dependency.
Key Numbers
CBD reduced tumor cell proportions in single-cell analysis. Dose-dependent reductions in ATP, glucose uptake, and lactate. HIF-1alpha agonist DMOG partially reversed effects. PTGS2 identified as central target.
How They Did This
Multi-omics approach including single-cell transcriptomics, network pharmacology, proteomics, in vitro functional assays, metabolic assays, rescue experiments, and synergy testing with glycolysis inhibitor 2-DG.
Why This Research Matters
Colorectal cancer cells reprogram their metabolism to grow faster (the Warburg effect). CBD's ability to disrupt this metabolic reprogramming represents a novel mechanism beyond simple cell killing, potentially making tumors more vulnerable to other treatments.
The Bigger Picture
Cancer metabolism is a growing therapeutic target. CBD's ability to attack cancer's energy supply through a specific molecular pathway adds to its multi-mechanism anticancer profile and could complement existing chemotherapy approaches.
What This Study Doesn't Tell Us
In vitro study primarily — in vivo validation is limited. Achievable tissue concentrations of CBD may differ from experimental doses. Single cancer type studied.
Questions This Raises
- ?Would CBD enhance standard colorectal cancer chemotherapy by disrupting metabolic resistance?
- ?Could metabolic biomarkers predict which patients might respond to CBD?
Trust & Context
- Key Stat:
- Evidence Grade:
- Comprehensive multi-omics approach with pathway validation, but primarily in vitro with limited in vivo confirmation.
- Study Age:
- Recent study applying cutting-edge multi-omics methods to understand CBD's anticancer mechanisms.
- Original Title:
- Cannabidiol Reprograms Glucose Metabolism in Colorectal Adenocarcinoma by Targeting HIF-1α/LDHA Pathway.
- Published In:
- The American journal of Chinese medicine, 53(8), 2561-2578 (2025)
- Authors:
- Zhang, Yuzhe, Gao, Zhengtao, Li, Yanke, Zhang, Lulu, Yan, Lirong, Liu, Aoran, Li, Fang, Peng, Xiaoli, Li, Ruipeng, Wang, Yan, Wu, Lina, Zhang, Ye
- Database ID:
- RTHC-08038
Evidence Hierarchy
Frequently Asked Questions
Can CBD treat colon cancer?
This lab study shows CBD can disrupt the abnormal metabolism cancer cells use to grow. Clinical trials would be needed before any treatment claims, but the mechanism is promising.
What is the Warburg effect?
Cancer cells reprogram their metabolism to consume more glucose and produce lactate even in the presence of oxygen. CBD disrupts this process by targeting key proteins (HIF-1alpha, LDHA) that drive it.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-08038APA
Zhang, Yuzhe; Gao, Zhengtao; Li, Yanke; Zhang, Lulu; Yan, Lirong; Liu, Aoran; Li, Fang; Peng, Xiaoli; Li, Ruipeng; Wang, Yan; Wu, Lina; Zhang, Ye. (2025). Cannabidiol Reprograms Glucose Metabolism in Colorectal Adenocarcinoma by Targeting HIF-1α/LDHA Pathway.. The American journal of Chinese medicine, 53(8), 2561-2578. https://doi.org/10.1142/S0192415X25500958
MLA
Zhang, Yuzhe, et al. "Cannabidiol Reprograms Glucose Metabolism in Colorectal Adenocarcinoma by Targeting HIF-1α/LDHA Pathway.." The American journal of Chinese medicine, 2025. https://doi.org/10.1142/S0192415X25500958
RethinkTHC
RethinkTHC Research Database. "Cannabidiol Reprograms Glucose Metabolism in Colorectal Aden..." RTHC-08038. Retrieved from https://rethinkthc.com/research/zhang-2025-cannabidiol-reprograms-glucose-metabolism
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.